$4.06 -0.08 (-1.93%)
12/3/2009 4:01 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating: 5 out of 5

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

Recs

0
Member Avatar TMFDitty (98.71) Submitted: 8/17/2008 11:22:55 PM : Outperform Start Price: $8.71 AOB Score: -41.26

Cheap PEG ratio, and FCF is starting to outstrip net income; the stock carries a 12x FCF valuation on an expected 32% grower.
The company seems to require minimal capex to grow, and its stock dilution is not too unreasonable at 5% over the past year. Looks like a safe bet.

Report this Post 0 Comments

Featured Broker Partners